Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

被引：0
|
作者：
Davis, Barry R.
Simpson, Lara M.
Black, Henry R.
Cushman, Wililam C.
Einhorn, Paula T.
Farber, Michael A.
Ford, Charles E.
Levy, Daniel
Massie, Barry M.
Nawaz, Shah
Nawaz, Shah
机构：
[1] Univ Texas, Sch Publ Hlth, Houston, TX USA
[2] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[3] Memphis VAMC, Memphis, TN USA
[4] NHLBI, DHVD, Bethesda, MD 20892 USA
[5] Pitman Internal Med Associates, Pittman, NJ USA
[6] NHLBI, Framingham Heart Study, Framingham, MA USA
[7] VAMC San Francisco, San Francisco, CA USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [1] Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Davis, Barry R.
    Kostis, John B.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, William C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    [J]. CIRCULATION, 2008, 118 (22) : 2259 - 2267
  • [2] Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Ebner, Christian
    [J]. JOURNAL FUR HYPERTONIE, 2009, 13 (03): : 36 - 38
  • [3] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [4] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    [J]. HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [5] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [6] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    [J]. CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [7] THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY
    Kholghi, Maedeh Khayyat
    Oparil, Suzanne
    Davis, Barry
    Tereshchenko, Larisa G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 752 - 752
  • [8] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [9] Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Dhruva, Sanket S.
    Huang, Chenxi
    Spatz, Erica S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt D.
    Davis, Barry R.
    Pressel, Sara L.
    Coifman, Ronald R.
    Krumholz, Harlan M.
    [J]. HYPERTENSION, 2017, 70 (01) : 94 - 102
  • [10] Blood pressure control in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Cushman, WC
    Ford, CE
    Cutler, JA
    Margolis, KL
    Davis, BR
    Grimm, RH
    [J]. CIRCULATION, 2002, 106 (19) : 476 - 476
12345